Below are the most recent publications written about "Cardiomyopathies" by people in Profiles.
-
Somavarapu AK, Ge J, Yengo CM, Craig R, Padron R. Cryo-EM reveals how cardiomyopathy therapeutic drugs modulate the myosin motors of the heart. Sci Adv. 2026 May; 12(18):eaed6472.
-
Rosenthal DN, Amodeo A, Butterfield RJ, Butts R, Chrzanowski S, Cripe L, Day J, Davies R, Duong T, Evers P, Gambetta K, Harris R, Hayes E, Kaufman B, Lorts A, Mack G, Mackenzie SJ, Mammen P, Markham L, McAlister J, McDonald C, Nakano SJ, Nandi D, Navaratnam M, Nelson S, Parent JJ, Piccoli C, Richmond M, Rocha C, Sawnani H, Schrader R, Shell R, Shih R, Shugh S, Smart T, Soslow J, Spinner J, Taivassalo T, Tunugtla H, VanderPluym C, Veerapandiyan A, Villa C, Wittlieb-Weber C, Zafarullah M, Hollander S. Heart Transplantation and Ventricular Assist Device in Duchenne Muscular Dystrophy: A New Era. Pediatr Transplant. 2026 01; 30(1):e70253.
-
Huynh J, Bilger MD, Berridge BR, Hendricks GM, Martinez-Romero EG, Mitchell RN, Reddig KR, Rush JE, Freeman LM. Myocardial ultrastructure in dogs and cats: review of normal structure, abnormal findings, and rationale for use in veterinary medicine. Am J Vet Res. 2026 Feb 01; 87(2).
-
Nuvvula S, Kakouros N, Alqalyoobi S, Stokken G, Mir T, Qureshi WT. Impact of ventricular arrhythmia in patients with sarcoidosis: an analysis of the national readmission database. Expert Rev Cardiovasc Ther. 2025 Aug; 23(8):469-475.
-
Ahmad S, Ahsan MJ, Newlun M, Sand M, Rmilah AA, Yousaf A, Shabbir MA, Malik SA, Goldsweig AM. Outcomes of aortic stenosis in patients with cardiac amyloidosis: A systematic review and meta-analysis. Cardiovasc Revasc Med. 2025 04; 73:98-106.
-
Satti DI, Choi E, Patel HP, Faisaluddin M, Mehta A, Patel B, Oyeka CP, Hegde S, Kwapong YA, Chan JSK, Anderson S, Ibrahim NE, Sinha SS, Dani SS, Sharma G. Cardiomyopathies in Pregnancy: Trends and Clinical Outcomes in Delivery Hospitalizations in the United States (2005-2020). Curr Probl Cardiol. 2024 Dec; 49(12):102855.
-
Fontana M, Berk JL, Gillmore JD, Witteles RM, Grogan M, Drachman B, Damy T, Garcia-Pavia P, Taubel J, Solomon SD, Sheikh FH, Tahara N, Gonz?lez-Costello J, Tsujita K, Morbach C, Pozsonyi Z, Petrie MC, Delgado D, Van der Meer P, Jabbour A, Bondue A, Kim D, Azevedo O, Hvitfeldt Poulsen S, Yilmaz A, Jankowska EA, Algalarrondo V, Slugg A, Garg PP, Boyle KL, Yureneva E, Silliman N, Yang L, Chen J, Eraly SA, Vest J, Maurer MS. Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy. N Engl J Med. 2025 01 02; 392(1):33-44.
-
Martin G, Narvaez-Guerra O, Aurigemma G, Kovell L. Peripartum ventricular tachycardia and PVC-induced cardiomyopathy: delivering optimal care when it's time to deliver. BMJ Case Rep. 2024 Jun 05; 17(6).
-
Tran KV, Donahue JK. Identifying the Role of Lipomatous Metaplasia in Ventricular Tachycardia Mechanism for Nonischemic Cardiomyopathy. JACC Clin Electrophysiol. 2024 06; 10(6):1147-1149.
-
Cheng R, Kittleson MM, Wechalekar AD, Alvarez-Cardona J, Mitchell JD, Scarlatelli Macedo AV, Dutra JPP, Campbell CM, Liu JE, Landau HJ, Davis MK, Morrissey S, Casselli S, Lousada I, Seabra-Garcez JD, Szor RS, Ganatra S, Trachtenberg B, Maurer MS, Stockerl-Goldstein K, Lenihan D. Moving towards establishing centres of excellence in cardiac amyloidosis: an International Cardio-Oncology Society statement. Heart. 2024 May 23; 110(12):823-830.